JP2025512119A5 - - Google Patents
Info
- Publication number
- JP2025512119A5 JP2025512119A5 JP2025503023A JP2025503023A JP2025512119A5 JP 2025512119 A5 JP2025512119 A5 JP 2025512119A5 JP 2025503023 A JP2025503023 A JP 2025503023A JP 2025503023 A JP2025503023 A JP 2025503023A JP 2025512119 A5 JP2025512119 A5 JP 2025512119A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210345658.0 | 2022-04-02 | ||
| CN202210345658.0A CN116925223A (zh) | 2022-04-02 | 2022-04-02 | 抗pd-1单克隆抗体及其衍生物和用途 |
| PCT/CN2023/085413 WO2023186077A1 (zh) | 2022-04-02 | 2023-03-31 | 抗pd-1单克隆抗体及其衍生物和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512119A JP2025512119A (ja) | 2025-04-16 |
| JP2025512119A5 true JP2025512119A5 (enExample) | 2026-04-08 |
Family
ID=88199450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025503023A Pending JP2025512119A (ja) | 2022-04-02 | 2023-03-31 | 抗ｐｄ－１モノクローナル抗体、その誘導体及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250297009A1 (enExample) |
| EP (1) | EP4520769A4 (enExample) |
| JP (1) | JP2025512119A (enExample) |
| CN (2) | CN116925223A (enExample) |
| WO (1) | WO2023186077A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119798436A (zh) * | 2023-10-10 | 2025-04-11 | 长春金赛药业有限责任公司 | 抗pd-1单克隆抗体及其应用 |
| CN120081943A (zh) * | 2024-04-16 | 2025-06-03 | 赛业（苏州）生物科技有限公司 | 一种人源化pd-l1抗体及其应用 |
| CN120518767B (zh) * | 2025-05-30 | 2025-11-11 | 中国人民解放军军事科学院军事医学研究院 | 一种pd-1单克隆抗体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DK1034298T3 (da) | 1997-12-05 | 2012-01-30 | Scripps Research Inst | Humanisering af murint antistof |
| EP1740615B1 (en) | 2004-03-31 | 2014-11-05 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| PE20170255A1 (es) * | 2014-01-24 | 2017-03-22 | Dana Farber Cancer Inst Inc | Moleculas de anticuerpo que se unen a pd-1 y usos de las mismas |
| CN114456269A (zh) * | 2016-09-21 | 2022-05-10 | 基石药业（苏州）有限公司 | 一种新的pd-1单克隆抗体 |
-
2022
- 2022-04-02 CN CN202210345658.0A patent/CN116925223A/zh active Pending
-
2023
- 2023-03-31 EP EP23778441.8A patent/EP4520769A4/en active Pending
- 2023-03-31 JP JP2025503023A patent/JP2025512119A/ja active Pending
- 2023-03-31 WO PCT/CN2023/085413 patent/WO2023186077A1/zh not_active Ceased
- 2023-03-31 CN CN202380031078.7A patent/CN118946587A/zh active Pending
- 2023-03-31 US US18/853,160 patent/US20250297009A1/en active Pending